Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of DARE-PTB1 in Healthy Postmenopausal Women
NCT06668896Phase 1Not yet recruiting
- Sponsor
- Daré Bioscience, Inc.
- Start
- Sep 2026
- Primary completion
- Nov 2027
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of progesterone in preterm birth (4 arms), sponsored by Daré Bioscience, Inc. Primary endpoint: Systemic pharmacokinetics of progesterone at 14 days. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
progesterone
03
Conditions
preterm birth
Beyond the preview
Go deeper on NCT06668896.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06668896.